SAN DIEGO, March 4, 2019 /PRNewswire/ -- Heron
Therapeutics, Inc. (NASDAQ: HRTX), a commercial-stage biotechnology
company focused on improving the lives of patients by developing
best-in-class treatments to address some of the most important
unmet patient needs, announced that Barry Quart, Pharm.D.,
President and Chief Executive Officer of Heron Therapeutics, will
present at the 39th Annual Cowen Healthcare Conference
on Monday, March 11, 2019, at
2:10 p.m. EST at The Boston Marriott
Copley Place.
A live webcast of this presentation will be available on the
Company's website at www.herontx.com in the Investor Resources
section. A replay of the presentation will be archived on the site
for 60 days.
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is a commercial-stage biotechnology
company focused on improving the lives of patients by developing
best-in-class treatments to address some of the most important
unmet patient needs. Heron is developing novel, patient-focused
solutions that apply its innovative science and technologies to
already-approved pharmacological agents for patients suffering from
pain or cancer.
For more information, visit www.herontx.com.
Forward-Looking Statements
This news release contains "forward-looking statements" as
defined by the Private Securities Litigation Reform Act of 1995.
Heron cautions readers that forward-looking statements are based on
management's expectations and assumptions as of the date of this
news release and are subject to certain risks and uncertainties
that could cause actual results to differ materially. These risks
and uncertainties include, but are not limited to, risks and
uncertainties identified in the Company's filings with the
Securities and Exchange Commission. Forward-looking statements
reflect our analysis only on their stated date, and Heron takes no
obligation to update or revise these statements except as may be
required by law.
Investor Relations and Media
Contact:
David
Szekeres
858-251-4447
Senior VP, General Counsel, Business Development and Corporate
Secretary
dszekeres@herontx.com
View original
content:http://www.prnewswire.com/news-releases/heron-therapeutics-to-present-at-the-39th-annual-cowen-healthcare-conference-300806108.html
SOURCE Heron Therapeutics, Inc.